You are here
INVESTOR PRESENTATION, PRIVATE PLACEMENT
26 November 2009: Please find enclosed the investor presentation used in relation to the private placement completed today, reference is made to previous announcement. Parts of this material will be presented by CEO Mårten Wigstøl at the DnB NOR Markets Healthcare Summit 2009 today; Thursday 26 November 2009.
Contact:
CEO Mårten Wigstøl - Phone: +47 911 65775
CFO Tone Kvåle - Phone: +47 915 19576
About NorDiag:
NorDiag is a biotechnology company developing, manufacturing and marketing automated solutions (instruments and tests) for sample preparation of DNA from difficult biological samples. DNA diagnostics give more rapid and precise answers, and is the fastest growing field within diagnostics. The company's sample preparation solutions are today used in connection with STI, tuberculosis, MRSA, respiratory pathogens and viruses on instruments for large and small laboratories. NorDiag was founded in 2003 and has its headquarters in Oslo, Norway. The company has offices and laboratories in Stockholm, Sweden, in West Chester (PA), USA and in Vienna, Austria. The group has today 40.1 man-labour years. NorDiag is listed on Oslo Stock Exchange with ticker NORD.
For further information - www.nordiag.com.
Read the notice in Norwegian here.